{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:12:25Z","timestamp":1791112345477,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1006\/exnr.2000.7374","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"239-243","source":"Crossref","is-referenced-by-count":117,"title":["Antiparkinsonian Actions of CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors"],"prefix":"10.1006","volume":"163","author":[{"given":"Kathy","family":"Steece-Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie K.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Jaw-Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Timothy","family":"Greenamyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2000.7374_RF1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2000.7374_RF2","first-page":"1034","article-title":"Differing effects of N-methyl-d-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys","volume":"290","author":"Blanchet","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.2000.7374_RF3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/116.2.433","article-title":"Electrophysiology of dopamine-denervated striatal neurons","volume":"116","author":"Calabresi","year":"1993","journal-title":"Brain"},{"key":"10.1006\/exnr.2000.7374_RF4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014Implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2000.7374_RF5","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1021\/jm00016a017","article-title":"(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-d-aspartate responses","volume":"38","author":"Chenard","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1006\/exnr.2000.7374_RF6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/138161280504230110102541","article-title":"Antagonists selective for NMDA receptors containing the NR2B subunit","volume":"5","author":"Chenard","year":"1999","journal-title":"Curr. Pharm. Des."},{"key":"10.1006\/exnr.2000.7374_RF7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2000.7374_RF8","first-page":"7","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1006\/exnr.2000.7374_RF9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01245235","article-title":"Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease","volume":"91","author":"Greenamyre","year":"1993","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.2000.7374_RF10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.410350605","article-title":"Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease","volume":"35","author":"Greenamyre","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7374_RF11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1113\/jphysiol.1996.sp021807","article-title":"A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones","volume":"497","author":"Kew","year":"1996","journal-title":"J. Physiol."},{"key":"10.1006\/exnr.2000.7374_RF12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.410300513","article-title":"The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys","volume":"30","author":"Klockgether","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7374_RF13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey Parkinsonism","volume":"6","author":"Kurlan","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2000.7374_RF14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02259538","article-title":"Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with l-Dopa in models of Parkinson's disease","volume":"3","author":"L\u00f6schmann","year":"1991","journal-title":"J. Neural. Transm. Parkinson's Dis. Sect."},{"key":"10.1006\/exnr.2000.7374_RF15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(97)10092-9","article-title":"CP-101,606, a potent neuroprotectant selective for forebrain neurons","volume":"331","author":"Menniti","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7374_RF16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1527-3458.1998.tb00073.x","article-title":"CP-101,606: An NR2B-selective NMDA receptor antagonist","volume":"4","author":"Menniti","year":"1998","journal-title":"CNS Drug Rev."},{"key":"10.1006\/exnr.2000.7374_RF17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/3661","article-title":"Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition","volume":"1","author":"Mott","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1006\/exnr.2000.7374_RF18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/exnr.1998.6963","article-title":"Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat","volume":"155","author":"Nash","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2000.7374_RF19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1006\/exnr.2000.7374_RF20","first-page":"A262","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7374_RF21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0165-6147(93)90005-5","article-title":"Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines","volume":"14","author":"Rogawski","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/exnr.2000.7374_RF22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903430102","article-title":"Organization of N-methyl-d-aspartate glutamate receptor gene expression in the basal ganglia of the rat","volume":"343","author":"Standaert","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7374_RF23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/syn.890190405","article-title":"Glutamate\/dopamine D1\/D2 balance in the basal ganglia and its relevance to Parkinson's disease","volume":"19","author":"Starr","year":"1995","journal-title":"Synapse"},{"key":"10.1006\/exnr.2000.7374_RF24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0701445","article-title":"Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist","volume":"122","author":"Taniguchi","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7374_RF25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1748-1716.1986.tb07939.x","article-title":"Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis","volume":"127","author":"Tossman","year":"1986","journal-title":"Acta Physiol. Scand."},{"key":"10.1006\/exnr.2000.7374_RF26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0959-4388(96)80024-9","article-title":"Functional and pathophysiological models of the basal ganglia","volume":"6","author":"Wichmann","year":"1996","journal-title":"Curr. Op. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600973746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600973746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T18:58:23Z","timestamp":1680548303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488600973746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0014488600973746"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2000.7374","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}